Revolution Medicines Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 18,407.1% | – | – | – | 71.9% | – | – | – | – | – | – | – | |
| – | 100.0% | – | – | – | -71.9% | – | – | – | – | – | – | – | |
| – | 20,010.9% | – | – | – | 71.9% | – | – | – | – | – | – | – | |
| – | 4,345.6% | – | – | – | 10.8% | – | – | – | – | – | – | – | |
| – | 24,356.5% | – | – | – | 82.7% | – | – | – | – | – | – | – | |
| – | -24,256.5% | – | – | – | -82.7% | – | – | – | – | – | – | – | |
| – | 1,251.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -21,724.3% | – | – | – | -74.7% | – | – | – | – | – | – | – | |
| – | 46.2% | – | – | – | -0.3% | – | – | – | – | – | – | – | |
| – | -21,770.5% | – | – | – | -74.4% | – | – | – | – | – | – | – | |
| – | -17,456.6% | – | – | – | -73.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.